Essential amino acids | Total (n = 47,337) | Quintile 1 | Quintile 2 | Quintile 3 | Quintile 4 | Quintile 5 | P for non-linearity |
---|---|---|---|---|---|---|---|
Median intake (g/day) | 26.30 | 16.90 | 22.27 | 26.31 | 30.86 | 39.05 | |
All-cause mortality | |||||||
Number of deaths | 9,231 | 2,093 | 1,797 | 1,634 | 1,734 | 1,973 | |
Model 1 | 1.16 (1.08–1.25) | 1.07 (1.00-1.14) | Ref | 1.03 (0.96–1.10) | 1.18 (1.10–1.27) | < 0.001 | |
Model 2 | 1.16 (1.07–1.26) | 1.08 (1.00-1.16) | Ref | 1.02 (0.95–1.10) | 1.06 (0.97–1.17) | < 0.001 | |
Cardiovascular mortality | |||||||
Number of deaths | 4,215 | 978 | 792 | 718 | 808 | 919 | |
Model 1 | 1.15 (1.03–1.28) | 1.04 (0.94–1.15) | Ref | 1.11 (1.00-1.23) | 1.32 (1.18–1.46) | < 0.001 | |
Model 2 | 1.23 (1.09–1.38) | 1.10 (0.99–1.23) | Ref | 1.09 (0.95–1.21) | 1.09 (0.95–1.25) | 0.003 | |
Cancer mortality | |||||||
Number of deaths | 1,887 | 398 | 401 | 342 | 357 | 389 | |
Model 1 | 1.30 (1.11–1.53) | 1.23 (1.06–1.43) | Ref | 0.95 (0.82–1.11) | 0.93 (0.79–1.09) | 0.241 | |
Model 2 | 1.17 (0.98–1.41) | 1.14 (0.98–1.33) | Ref | 0.97 (0.83–1.14) | 1.03 (0.83–1.27) | 0.174 | |
Other mortality | |||||||
Number of deaths | 3,373 | 772 | 662 | 614 | 614 | 711 | |
Model 1 | 1.10 (0.98–1.24) | 1.04 (0.93–1.16) | Ref | 0.98 (0.87–1.10) | 1.17 (1.04–1.32) | < 0.001 | |
Model 2 | 1.06 (0.93–1.21) | 1.02 (0.91–1.15) | Ref | 0.99 (0.87–1.11) | 1.08 (0.92–1.26) | 0.083 |